Sanofi
LIQUID PHARMACEUTICAL COMPOSITION
Last updated:
Abstract:
The present invention relates to a liquid pharmaceutical composition comprising a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. The composition of the present invention is suitable for medical use in humans, for example in the treatment of disorders of a metabolic syndrome or diabetes or obesity or for reduction of excess food intake.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2018
Issue date:
26 May 2022